Cadrenal Therapeutics (CVKD) Stock Chart & Stock Price History $11.17 -1.09 (-8.89%) Closing price 04:00 PM EasternExtended Trading$11.24 +0.07 (+0.63%) As of 04:19 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Cadrenal Therapeutics Stock Price Performance The Cadrenal Therapeutics (CVKD) stock chart highlights key performance trends across multiple timeframes. Since the beginning of the year, the stock decreased 22.91%. In the past month, the stock has decreased 18.47%, reflecting recent market activity. As of the latest close, Cadrenal Therapeutics traded at $12.26 with a market cap of $24.12 million and volume of 18,367 shares. Receive CVKD Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Cadrenal Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance-13.54%1 Month Performance-18.47%3 Month Performance-31.05%Year-To-Date Performance-22.91% CVKD Stock Chart for Wednesday, July, 16, 2025 CVKD Chart by TradingView Cadrenal Therapeutics Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization07/15/2025$12.50$12.26-1.92%$12.88$12.0018,367 shs$24.12 million07/14/2025$12.92$12.50-3.25%$13.00$12.3219,925 shs$24.59 million07/11/2025$13.00$12.92-0.62%$13.40$12.2726,636 shs$25.41 million07/10/2025$12.97$13.00+0.23%$13.63$12.9536,207 shs$25.61 million07/09/2025$12.68$12.97+2.29%$13.35$12.6544,151 shs$25.55 million07/08/2025$12.95$12.68-2.08%$13.56$12.6331,885 shs$24.94 million07/07/2025$12.29$12.95+5.37%$13.05$12.6043,068 shs$25.51 million07/04/2025$12.29$12.29$13.24$12.0420,178 shs$24.17 million07/03/2025$12.44$12.29-1.21%$13.24$12.0420,178 shs$24.21 million07/02/2025$11.67$12.44+6.60%$12.68$11.2147,780 shs$24.51 million Get the Latest News and Ratings for CVKD and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Cadrenal Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 07/01/2025$12.05$11.67-3.15%$12.32$11.0037,218 shs$22.99 million06/30/2025$10.44$12.05+15.42%$13.71$11.16179,701 shs$23.74 million06/27/2025$10.28$10.44+1.56%$10.84$10.1128,710 shs$20.57 million06/26/2025$10.35$10.28-0.68%$10.62$10.0222,440 shs$20.25 million06/25/2025$11.24$10.35-7.92%$11.09$10.2421,602 shs$20.36 million06/24/2025$11.44$11.24-1.75%$11.44$10.0045,902 shs$22.14 million06/23/2025$12.35$11.44-7.37%$13.30$11.0023,965 shs$22.54 million06/20/2025$13.39$12.35-7.77%$13.23$12.2715,057 shs$24.29 million06/19/2025$13.39$13.39$13.49$13.118,504 shs$26.38 million06/18/2025$13.13$13.39+1.98%$13.49$13.118,504 shs$26.38 million06/17/2025$13.70$13.13-4.16%$13.70$13.1215,015 shs$25.83 million06/16/2025$13.86$13.70-1.15%$13.99$13.4515,935 shs$26.95 million Related Companies ZNTL Stock Chart OPTN Stock Chart WHWK Stock Chart CTNM Stock Chart CLYM Stock Chart VXRT Stock Chart BYSI Stock Chart VIRI Stock Chart OCX Stock Chart IPA Stock Chart Receive CVKD Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Cadrenal Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:CVKD) was last updated on 7/16/2025 by MarketBeat.com Staff From Our PartnersBank of America Says Gold Could Hit $4,000. Here How to Get Paid“I’ve always hated gold. It doesn’t pay dividends… it just sits there.” That’s what one income strategist b...Investors Alley | SponsoredYour Bank Account Is No Longer SafeWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | SponsoredRevolutionary AI Tech Targets Early Diabetic Blindness Detection FDA Trial UnderwayTiny Stock, Massive Potential— this company’s AI platform is a game changer for healthcare!Interactive Offers | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | Sponsored3..2..1.. AI 2.0 ignition (don’t sleep on this)I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | Sponsored[ATTENTION] This Crypto Rocket Is About Launch…Every crypto bull market ends with a final surge — the window where fortunes are made fast. According to tw...Crypto Swap Profits | SponsoredTreasury Secretary Bessent Is Betting Big on GoldWhen the U.S. Treasury Secretary’s largest personal investment is gold — that’s a signal. Now a veteran gol...Golden Portfolio | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cadrenal Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Cadrenal Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free CVKD Stock Alerts